| At present,diseases threatening human health mainly include malignant tumors,cardiovascular and cerebrovascular diseases,infectious diseases and so on.This paper is focused on leukemia and Gram-negative bacteria related infectious diseases for the purpose of improving people’s quality of life.B progenitor acute lymphoblastic leukemia(B-ALL)is characterized by recurrent gross chromosomal alterations.Recently,several MEF2 D fusion partners were identified: BCL9,HNRNPUL1,DAZAP1,CSF1 R and SS18 among a small number of B-ALL patients.Compared with other subtypes,MEF2D-related leukemia shows poorer prognosis.For these newly discovered fusion genes,people still do not know much about the pathogenesis and mechanism of leukemia,so the exploration and research of its mechanism is a further expansion of the leukemia field,and also provides a theory for the treatment of B-ALL in clinic.Through the study of protein molecular level,we obtained the crystal structure of the complex of MEF2 D and DNA,and the diffraction resolution reached 3 angstroms,which can provide us with clear spatial structure information.Through structural information,we designed R3 A,K4A,K5 A.The R15 A,K23A,and K31 A mutations were verified by BLI and Luciferase experiments.These binding sites that interact with DNA can serve as potential targets for future leukemia treatment.Almost all the outer membrane proteins(OMPs)in gram-negative bacteria fold into a ?-barrel fold via the poly-POTRA motif and ?-barrel assembly machinery(BAM).However,the mechanism of the OMP-POTRA interaction/recruitment remains poorly understood.Until now,we have solved the crystal structure of H.influenzae poly-POTRAs.The H.influenzae poly-POTRAs structures revealed remarkable protein flexibility between different POTRA subunits.Furthermore,the phylogenetic analysis and structure-based sequence alignment of bacterial poly-POTRAs revealed an unexpected finding: more the POTRA subunits and protein flexibility,more lipo-associates are required.The restriction of POTRA-POTRA flexibility impaired the interactions of POTRA-lipoprotein,resulting in severe bacterial growth defect.Thus we can design drugs preventing OMP-POTRA interaction/recruitment to treat patients infected by gram-negative bacteria. |